Thank you for your interest in OBIO 2019 Niagara Investment Summit. Company applications for 2019 are now closed.
The Summit will bring Canada’s most promising health science companies to Niagara-on-the-Lake to present to and meet with global investors.
Highlighting companies across three fast-growing sectors:
New Frontiers in Medicine, including regenerative medicine, rare diseases, therapeutics, and medical devices
Artificial Intelligence in Health
Digital Health and Diagnostics
OBIO 2019 Niagara Investment Summit Eligibility
Companies based in Canada focused on developing health science products or services including but not limited to therapeutics, medical devices, diagnostics, or digital health which fit into the themes of the 2019 Niagara Investment Summit.
Companies based in Canada seeking to raise Series A and beyond investment.
Companies selected to participate in the 2019 Niagara Investment Summit will be on a rolling basis and presentation spots are limited. Interested companies should send an email to Christina Yeh (firstname.lastname@example.org) and include a non-confidential pitch deck (15 slides maximum), demonstrating how your company fits within the theme of the Summit.
OBIO 2019 Niagara Investment Summit Participation cost
Selected companies are responsible for the conference fee of $2,500 which includes:
Full registration for one company representative
An opportunity to pitch and hold one-on-one meetings with leading global investors
Attendance at a health science CEO roundtable dinner discussion
Two nights’ accommodation
Breakfast, lunch and dinner for the duration of the conference